Rebamipide with Proton Pump Inhibitors (PPIs) Versus PPIs Alone for the Treatment of Endoscopic Submucosal Dissection-Induced Ulcers: A Meta-analysis

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2020 Oct 16

PMID 33062694

Authors

Junyuan Liu

Zhencheng Xiong

Xuhua Geng

Meihua Cui

Affiliations

Soon will be listed here.

Abstract

Objective: To contrast the effect of rebamipide with proton pump inhibitors (PPIs) versus PPIs alone for the treatment of endoscopic submucosal dissection (ESD-) induced ulcers.

Methods: PubMed, Embase, the Cochrane library, the WanFang database, and China National Knowledge Infrastructure (CNKI) were searched to identify studies that met the inclusion criteria.

Results: Nine randomized controlled trials (RCTs) were recognized, including 1170 patients. In general, rebamipide plus PPIs acted better than PPIs alone against ESD-induced ulcers at four weeks (RR = 1.42, 95% CI: 1.13-1.78, = 0.003) but showed no significant differences at eight weeks (RR = 1.03, 95% CI: 0.97-1.10, = 0.315). The use of rebamipide plus PPIs was superior to PPIs alone for ESD-induced ulcers greater than 20 mm in size (20-40 mm: RR = 1.98, 95% CI: 1.22-3.23, = 0.006; >40 mm: RR = 5.14, 95% CI: 1.49-17.74, = 0.010). In addition, rebamipide plus PPI therapy was discovered to be significantly more effective than PPIs alone for lower ESD-induced ulcers (RR = 1.82, 95% CI: 1.04-3.20, = 0.037). There were no significant differences between the treatment groups with the ulcer reduction rate.

Conclusion: Evidences now available show rebamipide plus PPIs is practical for protecting against ESD-induced ulcers at four weeks but not at eight weeks, especially large ulcers (>20 mm). However, we still need more high-quality RCTs in the future to supplement our conclusions.

References

Banan A, Fitzpatrick L, Zhang Y, Keshavarzian A . OPC-compounds prevent oxidant-induced carbonylation and depolymerization of the F-actin cytoskeleton and intestinal barrier hyperpermeability. Free Radic Biol Med. 2001; 30(3):287-98. DOI: 10.1016/s0891-5849(00)00471-8. View

Araki H, Kato T, Onogi F, Ibuka T, Sugiyama A, Nakanishi T . Combination of proton pump inhibitor and rebamipide, a free radical scavenger, promotes artificial ulcer healing after endoscopic submucosal dissection with dissection size >40 mm. J Clin Biochem Nutr. 2012; 51(3):185-8. PMC: 3491242. DOI: 10.3164/jcbn.12-14. View

Lim J, Kim S, Choi J, Im J, Kim J, Jung H . Risk factors of delayed ulcer healing after gastric endoscopic submucosal dissection. Surg Endosc. 2015; 29(12):3666-73. DOI: 10.1007/s00464-015-4123-z. View

Kim M, Cho J, Cho J . Ever-changing endoscopic treatment for early gastric cancer: yesterday-today-tomorrow. World J Gastroenterol. 2014; 20(37):13273-83. PMC: 4188885. DOI: 10.3748/wjg.v20.i37.13273. View

Kakushima N, Fujishiro M, Yahagi N, Kodashima S, Nakamura M, Omata M . Helicobacter pylori status and the extent of gastric atrophy do not affect ulcer healing after endoscopic submucosal dissection. J Gastroenterol Hepatol. 2006; 21(10):1586-9. DOI: 10.1111/j.1440-1746.2006.04321.x. View

Fujiwara S, Morita Y, Toyonaga T, Kawakami F, Itoh T, Yoshida M . A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection. J Gastroenterol. 2011; 46(5):595-602. DOI: 10.1007/s00535-011-0372-3. View

Takayama M, Matsui S, Kawasaki M, Asakuma Y, Sakurai T, Kashida H . Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers. World J Gastroenterol. 2013; 19(34):5706-12. PMC: 3769909. DOI: 10.3748/wjg.v19.i34.5706. View

Du Y, Li Z, Zhan X, Chen J, Gao J, Gong Y . Anti-inflammatory effects of rebamipide according to Helicobacter pylori status in patients with chronic erosive gastritis: a randomized sucralfate-controlled multicenter trial in China-STARS study. Dig Dis Sci. 2008; 53(11):2886-95. DOI: 10.1007/s10620-007-0180-z. View

Asakuma Y, Kudo M, Matsui S, Okada M, Kawasaki M, Umehara Y . Comparison of an ecabet sodium and proton pump inhibitor (PPI) combination therapy with PPI alone in the treatment of endoscopic submucosal dissection (ESD)--induced ulcers in early gastric cancer: prospective randomized study. Hepatogastroenterology. 2009; 56(94-95):1270-3. View

10.

Sakurai K, Sasabe H, Koga T, Konishi T . Mechanism of hydroxyl radical scavenging by rebamipide: identification of mono-hydroxylated rebamipide as a major reaction product. Free Radic Res. 2004; 38(5):487-94. DOI: 10.1080/1071576042000209808. View

11.

Oh T, Jung H, Choi K, Lee G, Song H, Choi K . Degree of healing and healing-associated factors of endoscopic submucosal dissection-induced ulcers after pantoprazole therapy for 4 weeks. Dig Dis Sci. 2008; 54(7):1494-9. DOI: 10.1007/s10620-008-0506-5. View

12.

Higgins J, Altman D, Gotzsche P, Juni P, Moher D, Oxman A . The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928. PMC: 3196245. DOI: 10.1136/bmj.d5928. View

13.

Gisbert J, Gonzalez L, Calvet X, Roque M, Gabriel R, Pajares J . Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer. Aliment Pharmacol Ther. 2001; 15(7):917-26. DOI: 10.1046/j.1365-2036.2001.01012.x. View

14.

Nakamura K, Ihara E, Akiho H, Akahoshi K, Harada N, Ochiai T . Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy. Gut Liver. 2016; 10(6):917-924. PMC: 5087931. DOI: 10.5009/gnl15486. View

15.

Murakami K, Okajima K, Uchiba M, Harada N, Johno M, Okabe H . Rebamipide attenuates indomethacin-induced gastric mucosal lesion formation by inhibiting activation of leukocytes in rats. Dig Dis Sci. 1997; 42(2):319-25. DOI: 10.1023/a:1018861818023. View

16.

Yan B, Lu Z, Ge Z, Liu S, Guo X, Tian D . A Multicenter, Randomized, Controlled Trial of Rebamipide Plus Lansoprazole for the Treatment of Postendoscopic Submucosal Dissection Ulcers. Clin Transl Gastroenterol. 2019; 10(1):e00008. PMC: 6369969. DOI: 10.14309/ctg.0000000000000008. View

17.

Begg C, Mazumdar M . Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50(4):1088-101. View

18.

Kim H, Kim J, Kim J, Han J, Park S, Choi K . Preventive effects of rebamipide on NSAID-induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers. Dig Dis Sci. 2007; 52(8):1776-82. DOI: 10.1007/s10620-006-9367-y. View

19.

Kobayashi M, Takeuchi M, Hashimoto S, Mizuno K, Sato Y, Narisawa R . Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide. Dig Dis Sci. 2011; 57(1):119-26. DOI: 10.1007/s10620-011-1850-4. View

20.

Tanaka M, Ono H, Hasuike N, Takizawa K . Endoscopic submucosal dissection of early gastric cancer. Digestion. 2008; 77 Suppl 1:23-8. DOI: 10.1159/000111484. View